These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 2518765)
1. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa]. Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765 [TBL] [Abstract][Full Text] [Related]
2. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams. Lerner SA; Quinn JP Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267 [TBL] [Abstract][Full Text] [Related]
3. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy. Pagani L; Scarabelli M; Cereda PM; Debiaggi M Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759 [TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
5. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains. Michel-Briand Y; Nicolas T; Godard C; Plesiat P Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960 [TBL] [Abstract][Full Text] [Related]
6. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306 [TBL] [Abstract][Full Text] [Related]
7. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase]. López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634 [TBL] [Abstract][Full Text] [Related]
8. beta-Lactamases of Pseudomonas aeruginosa and susceptibility against beta-lactam antibiotics. Thabaut A; Philippon A; Meyran M Chemioterapia; 1985 Feb; 4(1):36-42. PubMed ID: 3921265 [TBL] [Abstract][Full Text] [Related]
9. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. Ciofu O; Giwercman B; Pedersen SS; Høiby N APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem. Yamano Y; Nishikawa T; Fujimura T; Yutsudou T; Tsuji M; Miwa H J Antibiot (Tokyo); 2006 Dec; 59(12):791-6. PubMed ID: 17323646 [TBL] [Abstract][Full Text] [Related]
12. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy. Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376 [TBL] [Abstract][Full Text] [Related]
13. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases]. Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345 [TBL] [Abstract][Full Text] [Related]
14. [Susceptibility to chemotherapeutics and the occurrence of metallo-beta-lactamases in hospital Pseudomonas aeruginosa strains]. Nowak P; Targosz A; Budak A; Oleksiak D; Geza G; Skałkowska M Med Dosw Mikrobiol; 2006; 58(3):231-7. PubMed ID: 17340998 [TBL] [Abstract][Full Text] [Related]
15. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria]. Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610 [TBL] [Abstract][Full Text] [Related]
16. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase. Wang C; Cai P; Chang D; Mi Z J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065 [No Abstract] [Full Text] [Related]
17. [Detection of hyperproduction of chromosomal beta-lactamase in strains of Escherichia coli, Enterobacter cloacae and Pseudomonas aeruginosa]. Roy C; Tirado M; Segura C; Esteva C; Teruel D Enferm Infecc Microbiol Clin; 1989; 7(6):301-6. PubMed ID: 2518766 [TBL] [Abstract][Full Text] [Related]
18. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Zhao WH; Hu ZQ Crit Rev Microbiol; 2010 Aug; 36(3):245-58. PubMed ID: 20482453 [TBL] [Abstract][Full Text] [Related]
19. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan. Yan JJ; Tsai SH; Chuang CL; Wu JJ J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245 [TBL] [Abstract][Full Text] [Related]
20. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. Gad GF; El-Domany RA; Zaki S; Ashour HM J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]